imATFIB ACTIVITIES
Activity T1
Development of an imaging-based method for fibrosis localization and quantification in the heart with atrial fibrillation.
Activity T2
Development of superparamagnetic MRI contrast agents using a core/shell design, with enhanced biocompatibility and low toxicity.
Activity T3
Identification of possible causes of persistent atrial fibrillation using correlation analysis of the imaging-derived parameters with patient clinical data.
Activity T4
Performing functional MRI on the affected heart segments to identify functional effects of the structural changes.
Activity T5
Activities for the acquisition and protection of industrial property rights.
Activity T6
Information and publicity activities.
Activity T7
Project management.